Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jumihaidokuto for acne vulgaris
jRCTs031220443Active, not recruiting
- Sponsor
- Kracie
- Start
- Jan 2023
- Countries
- 1
01
Overview
Randomised trial of jumihaidokuto in acne vulgaris (2 arms), sponsored by Kracie. Primary endpoint: Change in number of inflammatory rashes. Started Jan 2023; status: active, not recruiting.
02
Drugs
jumihaidokuto
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCTs031220443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220443.